Coordinated Care Opportunities Favor Pharmaceutical Companies in Connecticut, New Jersey and New York, According to HealthLeaders-InterStudy

July 11, 2012—Nashville, Tenn. —HealthLeaders-InterStudy, the leading provider of managed care market intelligence, finds that medical homes are gaining traction in the Tri-State area of Connecticut, New York and New Jersey. Numerous pilot programs are operating throughout New York state, which leads the nation in the number of practices recognized as medical homes by the National Committee for Quality Assurance.

Coordinated care opportunities could be a boon for pharmaceutical companies as partnerships between payers and providers are strengthened. The Tri-State region is bursting with medical homes and models of coordinated patient care that encourage more efficient uses of resources.

All three states are moving to improve care coordination for Medicaid members who are also Medicare beneficiaries through intensive outreach and management. Connecticut and New York are making use of medical homes for this population. In Connecticut neighborhood providers are expected to be affiliated with the medical homes, which already receive enhanced payments from the state for coordinating the care of state Medicaid patients.

Patient-centered medical home models for primary-care practices continue to grow in the New York City market. New York offers incentives to providers for their participation in patient-centered medical homes. Such programs could lead to increased opportunities for increased sales of branded drugs proven effective in reducing hospitalizations.

“Care coordination in medical homes is likely to enhance prescription drug compliance because of an emphasis on managing chronic conditions,” said HealthLeaders-InterStudy Senior Analyst Chris Lewis.